| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 07/02/2009 | CA2708407A1 Humanized anti-human cd34 antibody, the preparation method and uses thereof |
| 07/01/2009 | EP2075250A2 Thrombin receptor antagonists |
| 07/01/2009 | EP2074998A2 Use of cyclic bioisosteres of purine system derivatives for the treatment of diseases caused by disorders of nitrergic and dopaminergic systems |
| 07/01/2009 | EP2074131A2 Anticoagulant compounds |
| 07/01/2009 | EP2074112A1 Physiologically acceptable salts of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester |
| 07/01/2009 | EP2073821A1 Mixture of iron and copper salts masking metallic taste |
| 07/01/2009 | EP2073805A1 Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy |
| 07/01/2009 | EP2005948A9 Perfluorocarbon gas transferring emulsion for medico-biological use, the composition and the production method thereof a medicinal agent |
| 07/01/2009 | EP1537075B1 Diarylurea derivatives and their use as chloride channel blockers |
| 07/01/2009 | EP1527100B1 Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same |
| 07/01/2009 | EP1471054B1 Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these |
| 07/01/2009 | EP1423362B1 New mandelic acid derivative and its use as thrombin inhibitor |
| 07/01/2009 | EP1406858B1 Substituted 4-aminocyclohexanols |
| 07/01/2009 | EP1331977B1 Blood centrifuge cup having a replaceable compartment for filter support |
| 07/01/2009 | EP1250154B1 G-csf conjugates |
| 07/01/2009 | EP0871748B1 Delivery of biologically active polypeptides |
| 07/01/2009 | CN101468029A Difructose anhydride-containing composition and use thereof |
| 07/01/2009 | CN100506846C Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in treating viral infections and cancer |
| 07/01/2009 | CN100506791C Pentafluorosulfanylbenzoylguanidines, preparation method, their use as medicaments or diagnostic aids, and medicaments comprising them |
| 07/01/2009 | CN100506277C Combinations of antibodies selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and other therapeutic agents |
| 07/01/2009 | CN100506275C Propagation increasing action of osteogenic growth peptide to hemopoietic progenitor cell and application |
| 06/30/2009 | USRE40811 Administering anti-VLA-4 antibody (or anti-VCAM-1 antibody) which blocks binding VLA-4 antigen on surface of CD34 cells to VCAM-1 or fibronectin, thereby increasing number of CD34+ cells in peripheral blood; colony stimulating factors |
| 06/30/2009 | US7553877 Use of 2-hydroxy-1,2,3,4,4a,9,10,10a-octahydrophenanthrene compounds glucocorticoid receptor agonists to treat certain inflammatory conditions such as arthritis, asthma |
| 06/30/2009 | US7553852 Caspase inhibitors and uses thereof |
| 06/30/2009 | US7553823 C-pyrazole A2A receptor agonists |
| 06/30/2009 | US7553613 Coagulation, mechanical agitation; filtration |
| 06/30/2009 | US7553479 Heat stable colloidal iron oxides coated with reduced carbohydrates and uses thereof |
| 06/30/2009 | CA2295101C Adenosine a1 receptor antagonist containing composition and method for restoring diuretic and renal function |
| 06/25/2009 | WO2009079401A2 Compositions and methods for increasing iron absorption |
| 06/25/2009 | WO2009049961A3 New no-donor aspirin derivatives |
| 06/25/2009 | WO2008046084A3 Spiroheterocyclic compounds and their uses as therapeutic agents |
| 06/25/2009 | US20090163556 Glycinamide derivatives as raf-kinase inhbitors |
| 06/25/2009 | US20090163547 Indene derivatives, their preparation and use as medicaments |
| 06/25/2009 | US20090163418 Resuscitation fluid |
| 06/25/2009 | US20090163417 Activin-actrii antagonists and uses for increasing red blood cell levels |
| 06/25/2009 | US20090162429 Slow-Release Composition, Method for the Preparation Thereof, and Use Thereof |
| 06/25/2009 | US20090162413 Compositions and methods of administering rapamycin analogs with paclitaxel using medical devices |
| 06/25/2009 | US20090162386 Chondrocyte therapeutic delivery system |
| 06/25/2009 | US20090162314 Magnesium-Containing Polymers for the Treatment of Hyperphosphatemia |
| 06/25/2009 | US20090162282 Substituted 4--piperidine-1-carboxylic acid esters as a2ar agonists |
| 06/25/2009 | DE102007060172A1 New nitrogen substituted heterocyclic compounds are glycogen synthase kinase 3-beta inhibitors useful e.g. to treat and/or prevent hematological disease, preferably leukopenia, and for ex-vivo increase of adult hematopoietic stem cells |
| 06/25/2009 | CA2709159A1 Compositions and methods for increasing iron absorption |
| 06/24/2009 | EP1499746A4 Method to inhibit cell growth using oligonucleotides |
| 06/24/2009 | EP1131106B1 Compositions and methods for producing vascular occlusion |
| 06/24/2009 | CN101466435A Use of KW-3902 for achieving diuresis in patients with congestive heart failure and acute fluid overload |
| 06/24/2009 | CN101461804A (+)-1-(3,4-dichlorrophenyl)-3-azabicyclo[3.1.0]hexane, compositions and uses thereof |
| 06/24/2009 | CN100503608C Deazapurines and uses thereof |
| 06/24/2009 | CN100503572C Caspase inhibitors and uses thereof |
| 06/24/2009 | CN100503570C Cyanoguanidine prodrugs |
| 06/24/2009 | CN100502919C Pill for treating varicosity and thrombophlebitis |
| 06/24/2009 | CN100502902C Honeysuckle and baical skullcap root combination, oral preparation and injection preparation containing same, its preparing method and application |
| 06/24/2009 | CN100502901C Extraction method for effective parts of salvia |
| 06/23/2009 | US7550567 Contaminating proteins are depleted by negative chromatography and/or negative adsorption using cation exchanger, hydrophobic gel and/or dye gel; improved stability; fibrin glue |
| 06/23/2009 | US7550507 2-(alpha-hydroxypentyl) benzoate and its preparation and use |
| 06/23/2009 | US7550499 Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions |
| 06/23/2009 | US7550494 Small molecules useful in the treatment of inflammatory disease |
| 06/23/2009 | US7550476 Condensed polycyclic compounds |
| 06/23/2009 | US7550475 Use of phosphodiesterase 4 inhibitors such as 6,7-dimethoxy-1-[2-(1,3-dioxocyclohexan-2-yl)pyridin-4-yl]-2,3-bis(hydroxymethyl)naphthalene to treat asthma, chronic obstructive pulmonary disease, atopic dermatitis, allergic rhinitis, psoriasis, rheumatoid arthritis, septic shock, ulcerative colitis |
| 06/23/2009 | US7550474 Anticoagulants; strokes; restenosis; antiinflamamtory agents |
| 06/23/2009 | US7550464 Use of phosphodiesterase 4 inhibitors such as 8,9-dimethoxy-6-phenyl-1,3,4,6,11,11a-hexahydro-2H -pyrazino[1,2-b]isoquinoline for treating asthma, chronic obstructive pulmonary disease, atopic dermatitis, allergic rhinitis, psoriasis, rheumatoid arthritis, septic shock, ulcerative colitis |
| 06/23/2009 | US7550446 Modified hydroxyethyl- or hydroxypropyl-substituted starch product for clinical use, which has a degree of branching of 8-10 mol %, a degree of substitution of up to 0.3, an average molecular weight of 10000- 450000; product is not derived from an amylopectin fraction |
| 06/23/2009 | CA2492804C Novel inhibitors of kinases |
| 06/23/2009 | CA2430967C Remedies for bone marrow suppression and infectious diseases and white blood cell count elevating agents |
| 06/23/2009 | CA2389219C Dry powder compositions having improved dispersivity |
| 06/23/2009 | CA2373466C Application of aprataxin gene to diagnosis and treatment for early-onset spinocerebellar ataxia (eaoh) |
| 06/23/2009 | CA1341597C Mutant human tissue-type plasminogen activator with a modified carbohydrate structure at amino acid residue 117 |
| 06/18/2009 | WO2009076664A1 Method and composition for treating a serotonin receptor-mediated condition |
| 06/18/2009 | WO2009074259A1 Triazolotriazines and triazolopyrazines and the use thereof |
| 06/18/2009 | WO2009074249A1 Oxazolidinones for the treatment and/or prophylaxis of heart failure |
| 06/18/2009 | WO2009074018A1 Medical use of ginsenoside or their mixture and composition thereof |
| 06/18/2009 | WO2009073916A1 Improved treatment and prophylaxis |
| 06/18/2009 | WO2009073911A1 Treatment and prophylaxis |
| 06/18/2009 | US20090156803 Condensed furan compounds |
| 06/18/2009 | US20090156665 Compositions Comprising Flavonoids and Toctrienols and Methods Thereof |
| 06/18/2009 | US20090156640 Nociceptin analogs |
| 06/18/2009 | US20090156633 Heterocyclic quinolone derivatives that inhbit prolyl hydroxylase activity |
| 06/18/2009 | US20090156620 [4-(6-fluoro-7-methylamino-2,4-dioxo-1,4-dihydro-2h-quinazolin-3-yl)-phenyl]-5-chloro-thiophen-2-yl-sulfonylurea salts, forms and methods related thereto |
| 06/18/2009 | US20090156619 Heterocycle Substituted Amide and Sulfur Amide Derivatives as Histone Deacetylase (HDAC) Inhibitors |
| 06/18/2009 | US20090156598 Imidazolopyrimidine modulators of TRPV1 |
| 06/18/2009 | US20090156546 Compositions and methods for modulating the immune system |
| 06/18/2009 | US20090156534 Globin lentiviral vectors for treatment of disease |
| 06/18/2009 | US20090156504 Methods of treating blood cell depletion |
| 06/18/2009 | US20090156481 Use of Factor VIIa or Factor VIIa Equivalents for Preventing or Attenuating Haemorrhage Growth, and/or Oedema Generation Following Intracerebral Haemorrhage (ICH) in Patients Treated with Antiplatelet Therapy |
| 06/18/2009 | US20090155912 Method for transfer of molecular substances with prokaryontic nucleic acid-binding proteins |
| 06/18/2009 | US20090155897 Glycoprotein vi fusion proteins |
| 06/18/2009 | US20090155281 Methods of using antibodies that bind both bcma and taci |
| 06/18/2009 | US20090155205 HUMAN ANTIBODIES THAT BIND HUMAN TNFa |
| 06/18/2009 | US20090155203 Thrombopoietin mimetics |
| 06/18/2009 | CA2746551A1 Improved treatment and prophylaxis |
| 06/18/2009 | CA2709104A1 Method and composition for treating a serotonin receptor-mediated condition |
| 06/18/2009 | CA2708783A1 Triazolotriazines and triazolopyrazines and the use thereof |
| 06/17/2009 | EP2071036A2 Methods for identifying RNA-binding compounds |
| 06/17/2009 | EP2070939A1 Modulators of pharmacological agents |
| 06/17/2009 | EP2070930A1 Polycycloalkylpurines as adenosine receptor antagonists |
| 06/17/2009 | EP2070920A1 Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and 1-oxoisoindolines and method of reducing TNF alpha levels |
| 06/17/2009 | EP2070908A1 Compound having benzamide skeleton and cyclooxygenase (cox-1)-selective inhibitory activity |
| 06/17/2009 | EP2070535A1 Drugs for relieving carbonyl stress and peritoneal dialysates |
| 06/17/2009 | EP2069326A2 Bicyclic and tricyclic derivatives as thrombin receptor antagonists |
| 06/17/2009 | EP2069288A1 TARTRATE DERIVATIVES FOR USE AS COAGULATION FACTOR IXa INHIBITORS |
| 06/17/2009 | EP2068932A2 Compositions and drug-delivery systems comprising rapamycin analogs and paclitaxel |